Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 months to 65 years
- People who have epilepsy that focuses in one area of the brain, does not respond well to medication, and significantly affects daily life
- People (or their parent or guardian, for minors) who are informed about the study and willing to sign a consent form approved by an ethics committee — if one parent is unavailable within the required timeframe, one parent's signature may be accepted
- People who are covered by French social security or an equivalent recognised scheme
- For new participants joining going forward: people being considered for a brain monitoring procedure called SEEG as part of an assessment to see whether epilepsy surgery may help
- For participants being included based on past and future data: people who have already had a SEEG procedure using a specific device (ALCIS) before the study's start visit, who have had at least 12 months of follow-up visits planned going forward, and for whom complete records are available from all previous visits (confirm with trial site)
Who may not be able to join:
- People who, in the assessor's judgement, would not be able to follow the study procedures — for example, difficulty understanding study questions or being unable to attend scheduled appointments
- People with any medical condition that the investigator believes could affect the study, such as relevant allergies (confirm with trial site)
- People who are pregnant, as the SEEG procedure is not considered safe during pregnancy
- Adults who are under a legal protection order (for example, under guardianship)
- People whose skull thickness measures less than 2 mm
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 (0)3 81 61 54 16
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Signal quality; Modification of Electroencephalography trace post-coagulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.